3-Hydroxy Repaglinide, a primary CYP2C8 metabolite of Repaglinide, is derived from carbamoylmethyl benzoic acid and is used in the treatment of type II diabetes.
Molecular Weight:
468.59
CAS Number:
[874908-14-2]
Formula:
C27H36N2O5
Target:
Others|||Drug Metabolite
T13497
* VAT and and shipping costs not included. Errors and price changes excepted